15 下列何藥之作用不是阻斷血小板之 glycoprotein IIb/IIIa 接受器?
(A)Abciximab
(B)Dipyridamole
(C)Eptifibatide
(D)Tirofiban
答案:登入後查看
統計: A(370), B(2244), C(126), D(201), E(0) #415682
統計: A(370), B(2244), C(126), D(201), E(0) #415682
詳解 (共 10 筆)
#992604
Aspirin:抑制cyclooxygenase,使血小板無法生成TXA2。
Clopidogrel:選擇性的抑制血小板上ADP受體
Dipyridamole:抑制紅血球、血小板及內皮細胞對腺核苷(adenosine)的再回收
Ticlopidine:和clopidogrel之作用機轉相同。
52
1
#3399349
阻斷血小板之 glycoprotein IIb/IIIa 接受器: abciximab eptifibatide Tirofaban
字根幾乎都有ab或ba
Aspirin:抑制cyclooxygenase,使血小板無法生成TXA2。
Ticlopidine /Clopidogrel :選擇性的抑制血小板上ADP受體
Dipyridamole:抑制紅血球、血小板及內皮細胞對腺核苷(adenosine)的再回收
DC
28
1
#2654115
阻斷血小板之 glycoprotein IIb/IIIa 接受器: abciximab eptifibatide Tirofaban
13
1
#1485717
Dipyridamole is a phosphodiesterase inhibitor, which inhibits platelet aggregation. Management of chronic angina pectoris thromboembolic disease; Dipyridamole is useful in preventing thromboembolism in patients who have received prosthetic heart valves.
4
1